Q2 2024 |
91 |
$399M |
+$66M |
-$65.4M |
+$521K |
AVGO, NTAP, MATX, SYK, EMR
|
13F-HR |
7/19/2024, 08:03 PM |
Q1 2024 |
91 |
$404M |
+$40.3M |
-$32.6M |
+$7.76M |
VLO, STLD, CAT, CBT, NTAP
|
13F-HR |
4/22/2024, 10:33 AM |
Q4 2023 |
86 |
$359M |
+$70.9M |
-$78.4M |
-$7.53M |
AVGO, CAT, EGLE, GD, MATX
|
13F-HR |
2/5/2024, 12:35 PM |
Q3 2023 |
101 |
$333M |
+$20.8M |
-$12.9M |
+$7.94M |
AAPL, JPM, ISMD, VLO, CAT
|
13F-HR |
10/30/2023, 11:53 AM |
Q2 2023 |
102 |
$351M |
+$24.8M |
-$12M |
+$12.8M |
AAPL, JPM, ISMD, AVGO, BLDR
|
13F-HR |
7/18/2023, 11:33 AM |
Q1 2023 |
100 |
$322M |
+$47.6M |
-$12.3M |
+$35.3M |
AAPL, JPM, ISMD, BLES, AVGO
|
13F-HR |
4/10/2023, 03:11 PM |
Q4 2022 |
94 |
$271M |
+$25.8M |
-$12.1M |
+$13.7M |
JPM, AAPL, ISMD, BLES, CAT
|
13F-HR |
1/24/2023, 03:43 PM |
Q3 2022 |
98 |
$254M |
+$36.9M |
-$2.3M |
+$34.6M |
AAPL, ISMD, JPM, BLES, GD
|
13F-HR |
10/17/2022, 06:23 PM |
Q2 2022 |
98 |
$265M |
+$39.8M |
-$8.4M |
+$31.4M |
AAPL, JPM, ISMD, BLES, GD
|
13F-HR |
7/11/2022, 04:37 PM |
Q1 2022 |
98 |
$305M |
+$16M |
-$1.57M |
+$14.4M |
AAPL, JPM, ISMD, BLES, SPTN
|
13F-HR |
4/14/2022, 05:32 PM |
Q4 2021 |
87 |
$268M |
+$28.9M |
-$5.77M |
+$23.1M |
AAPL, JPM, ISMD, BLES, XPRO
|
13F-HR |
2/2/2022, 06:05 PM |
Q3 2021 |
102 |
$329M |
+$24.7M |
-$17.1M |
+$7.62M |
JPM, ISMD, AAPL, BIBL, BLES
|
13F-HR |
11/15/2021, 06:24 AM |
Q2 2021 |
98 |
$308M |
+$28.3M |
-$15.6M |
+$12.6M |
JPM, ISMD, AAPL, BIBL, BLES
|
13F-HR |
8/16/2021, 02:40 PM |
Q1 2021 |
100 |
$301M |
+$69.4M |
-$25.9M |
+$43.5M |
JPM, ISMD, FI, BLES, BIBL
|
13F-HR |
5/17/2021, 06:06 PM |
Q4 2020 |
85 |
$226M |
|
|
|
BLES, BIBL, ISMD, FI, NTAP
|
13F-HR |
1/29/2021, 10:23 AM |